ICAD: Clinical validation study of a new algorithm for oral anticoagualant dosing.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON26250

Enrollment

712

Registered

2006-07-31

Start date

2003-08-14

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anticoagulant treatment.

Interventions

Oral anticoagulant dosage supported by the new algorithm (ICAD) and oral anticoagulant dosage supported by the algorithm TRODIS.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Indication for longterm anticoagulant therapy; 2. Age between 18 and 80.

Exclusion criteria

Exclusion criteria: 1. Paticipation in the patient selfmanagement program; 2. Staying long periods abroad; 3. Terminal stage of disease.

Design outcomes

Primary

Measure	Time frame
Percentage of time therapeutic range, proportion of visits in shich the algorithm gave a proposal and the proportion that was accepted by the physician.	—

Secondary

Measure	Time frame
1. Mean time between visits; 2. Bleeding events; 3. Thrombotic events.	—

Contacts

Public ContactY. Leeuwen, van

Leiden University Medical Center (LUMC), Department of Clinical Epidemiology, P.O. Box 9600

y.van_leeuwen@lumc.nl+31 (0)71 5261384

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)